Cargando…
Disease modification in osteoarthritis; pathways to drug approval
OBJECTIVE: To summarize proceedings of a workshop convened to discuss advances in disease modifying osteoarthritis (OA) drugs and regulatory challenges in bringing these drugs to market. DESIGN: Summary of a one day workshop held in Washington, DC in May 2019. RESULTS: Attendees presented data docum...
Autores principales: | Katz, Jeffrey N., Neogi, Tuhina, Callahan, Leigh F., Block, Joel A., Conaghan, Philip G., Simon, Lee S., Kraus, Virginia Byers, Hochberg, Marc C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718177/ https://www.ncbi.nlm.nih.gov/pubmed/36474586 http://dx.doi.org/10.1016/j.ocarto.2020.100059 |
Ejemplares similares
-
Clinical significance of bone changes in osteoarthritis
por: Neogi, Tuhina
Publicado: (2012) -
How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? Data from the Osteoarthritis Initiative
por: Kingsbury, Sarah R, et al.
Publicado: (2013) -
Osteoarthritis Research Society International (OARSI): Past, present and future
por: Mobasheri, Ali, et al.
Publicado: (2021) -
Tibiofemoral knee osteoarthritis progresses symmetrically by knee compartment in the GOGO cohort
por: Alexander, Louie C., et al.
Publicado: (2022) -
Extracellular Vesicles as Biological Indicators and Potential Sources of Autologous Therapeutics in Osteoarthritis
por: Zhang, Xin, et al.
Publicado: (2021)